Literature DB >> 29241006

Toxoid Vaccination against Bacterial Infection Using Cell Membrane-Coated Nanoparticles.

Pavimol Angsantikul1, Ronnie H Fang1, Liangfang Zhang1.   

Abstract

As nanoparticles exhibit unique properties attractive for vaccine development, they have been progressively implemented as antigen delivery platforms and immune potentiators. Recently, cell membrane-coated nanoparticles have provided a novel approach for intercepting and neutralizing bacterial toxins by leveraging their natural affinity to cellular membranes. Such toxin-nanoparticle assemblies, termed nanotoxoids, allow rapid loading of different types of toxins and have been investigated for their ability to effectively confer protection against bacterial infection. This topical review will cover the current progress in antibacterial vaccine nanoformulations and highlight the nanotoxoid platform as a novel class of nanoparticulate vaccine. We aim to provide insights into the potential of nanotoxoids as a platform that is facile to implement and can be broadly applied to help address the rising threat of super pathogens.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29241006      PMCID: PMC5893865          DOI: 10.1021/acs.bioconjchem.7b00692

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  93 in total

1.  Reorienting our view of particle-based adjuvants for subunit vaccines.

Authors:  Steven R Little
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

Review 2.  Bioengineering bacterial outer membrane vesicles as vaccine platform.

Authors:  Matthias J H Gerritzen; Dirk E Martens; René H Wijffels; Leo van der Pol; Michiel Stork
Journal:  Biotechnol Adv       Date:  2017-05-15       Impact factor: 14.227

3.  Optimization of encapsulation of a synthetic long peptide in PLGA nanoparticles: low-burst release is crucial for efficient CD8(+) T cell activation.

Authors:  A L Silva; R A Rosalia; A Sazak; M G Carstens; F Ossendorp; J Oostendorp; W Jiskoot
Journal:  Eur J Pharm Biopharm       Date:  2012-11-29       Impact factor: 5.571

4.  Nanovaccinology: the next generation of vaccines meets 21st century materials science and engineering.

Authors:  Tewodros Mamo; Gregory A Poland
Journal:  Vaccine       Date:  2012-10-19       Impact factor: 3.641

5.  Nanoparticle-Based Antivirulence Vaccine for the Management of Methicillin-Resistant Staphylococcus aureus Skin Infection.

Authors:  Fei Wang; Ronnie H Fang; Brian T Luk; Che-Ming J Hu; Soracha Thamphiwatana; Diana Dehaini; Pavimol Angsantikul; Ashley V Kroll; Zhiqing Pang; Weiwei Gao; Weiyue Lu; Liangfang Zhang
Journal:  Adv Funct Mater       Date:  2016-02-05       Impact factor: 18.808

6.  Oral Helicobacter pylori vaccine-encapsulated acid-resistant HP55/PLGA nanoparticles promote immune protection.

Authors:  Zhoulin Tan; Wei Liu; Hai Liu; Cheng Li; Yan Zhang; Xia Meng; Tingting Tang; Tao Xi; Yingying Xing
Journal:  Eur J Pharm Biopharm       Date:  2016-11-16       Impact factor: 5.571

7.  Identification of formaldehyde-induced modifications in proteins: reactions with model peptides.

Authors:  Bernard Metz; Gideon F A Kersten; Peter Hoogerhout; Humphrey F Brugghe; Hans A M Timmermans; Ad de Jong; Hugo Meiring; Jan ten Hove; Wim E Hennink; Daan J A Crommelin; Wim Jiskoot
Journal:  J Biol Chem       Date:  2003-11-24       Impact factor: 5.157

8.  Targeting vault nanoparticles to specific cell surface receptors.

Authors:  Valerie A Kickhoefer; Muri Han; Sujna Raval-Fernandes; Michael J Poderycki; Raymond J Moniz; Dana Vaccari; Mariena Silvestry; Phoebe L Stewart; Kathleen A Kelly; Leonard H Rome
Journal:  ACS Nano       Date:  2009-01-27       Impact factor: 15.881

9.  Pregnancy Vaccination with Gold Glyco-Nanoparticles Carrying Listeria monocytogenes Peptides Protects against Listeriosis and Brain- and Cutaneous-Associated Morbidities.

Authors:  Ricardo Calderón-Gonzalez; Héctor Terán-Navarro; Elisabet Frande-Cabanes; Eva Ferrández-Fernández; Javier Freire; Soledad Penadés; Marco Marradi; Isabel García; Javier Gomez-Román; Sonsoles Yañez-Díaz; Carmen Álvarez-Domínguez
Journal:  Nanomaterials (Basel)       Date:  2016-08-19       Impact factor: 5.076

10.  Immunoadjuvant potential of cross-linked dextran microspheres mixed with chitosan nanospheres encapsulated with tetanus toxoid.

Authors:  Haniyeh Pirouzmand; Bahman Khameneh; Mohsen Tafaghodi
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

View more
  17 in total

Review 1.  Engineering biological interactions on the nanoscale.

Authors:  Yao Jiang; Sanam Chekuri; Ronnie H Fang; Liangfang Zhang
Journal:  Curr Opin Biotechnol       Date:  2018-11-01       Impact factor: 9.740

Review 2.  Biomimetic nanoparticle technology for cardiovascular disease detection and treatment.

Authors:  Joon Ho Park; Diana Dehaini; Jiarong Zhou; Maya Holay; Ronnie H Fang; Liangfang Zhang
Journal:  Nanoscale Horiz       Date:  2019-06-28       Impact factor: 10.989

Review 3.  Biomimetic Nanotechnology toward Personalized Vaccines.

Authors:  Jiarong Zhou; Ashley V Kroll; Maya Holay; Ronnie H Fang; Liangfang Zhang
Journal:  Adv Mater       Date:  2019-06-17       Impact factor: 30.849

4.  Biomimetic Nanoparticle Vaccines for Cancer Therapy.

Authors:  Ashley V Kroll; Yao Jiang; Jiarong Zhou; Maya Holay; Ronnie H Fang; Liangfang Zhang
Journal:  Adv Biosyst       Date:  2018-11-13

Review 5.  Nanoparticle-hydrogel superstructures for biomedical applications.

Authors:  Yao Jiang; Nishta Krishnan; Jiyoung Heo; Ronnie H Fang; Liangfang Zhang
Journal:  J Control Release       Date:  2020-05-26       Impact factor: 9.776

Review 6.  Bacteria-Inspired Nanomedicine.

Authors:  Maya Holay; Zhongyuan Guo; Jessica Pihl; Jiyoung Heo; Joon Ho Park; Ronnie H Fang; Liangfang Zhang
Journal:  ACS Appl Bio Mater       Date:  2020-10-08

7.  Unleashing the potential of cell membrane-based nanoparticles for COVID-19 treatment and vaccination.

Authors:  Miguel Pereira-Silva; Gaurav Chauhan; Matthew D Shin; Clare Hoskins; Marc J Madou; Sergio O Martinez-Chapa; Nicole F Steinmetz; Francisco Veiga; Ana Cláudia Paiva-Santos
Journal:  Expert Opin Drug Deliv       Date:  2021-06-06       Impact factor: 6.648

8.  Biomimetic Nanoparticles Camouflaged in Cancer Cell Membranes and Their Applications in Cancer Theranostics.

Authors:  Jiefu Jin; Zaver M Bhujwalla
Journal:  Front Oncol       Date:  2020-01-21       Impact factor: 6.244

Review 9.  Human lung-on-chips: Advanced systems for respiratory virus models and assessment of immune response.

Authors:  Ecem Saygili; Ece Yildiz-Ozturk; Macauley J Green; Amir M Ghaemmaghami; Ozlem Yesil-Celiktas
Journal:  Biomicrofluidics       Date:  2021-03-23       Impact factor: 2.800

10.  CD4+ T Cell-Mimicking Nanoparticles Broadly Neutralize HIV-1 and Suppress Viral Replication through Autophagy.

Authors:  Gang Zhang; Grant R Campbell; Qiangzhe Zhang; Erin Maule; Jonathan Hanna; Weiwei Gao; Liangfang Zhang; Stephen A Spector
Journal:  mBio       Date:  2020-09-15       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.